Nuwellis

Yahoo Finance • 13 days ago

Monday's after hours session: top gainers and losers

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements. [postmarket] GAINERS TICKER CHANGE COMMENT WBTN [https://www.chartmill.com/stock/quote/WBTN/profile] 71.66%... Full story

Yahoo Finance • 24 days ago

Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management

MINNEAPOLIS, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc., a fluid management company, announced plans to introduce a new 24-hour circuit for Aquadex therapy in the United States this fall. The new circuit is designed for single-day... Full story

Yahoo Finance • last month

Nuwellis receives FDA clearance for new size of dual lumen catheter

Nuwellis, Inc. (NASDAQ:NUWE), a medical device company with a market capitalization of $2.93 million, announced Thursday that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for a new size of its Dual Lumen Extende... Full story

Yahoo Finance • last month

Form 8K Nuwellis Inc For: 21 August

... Full story

Yahoo Finance • last month

Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter

MINNEAPOLIS, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on fluid management, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for a new si... Full story

Yahoo Finance • last month

Nuwellis announces non-binding letter of intent to acquire Rendiatech

Nuwellis, Inc. (NASDAQ:NUWE), a medical device company with a market capitalization of $3.3 million and annual revenue of $8.3 million, announced Tuesday that it has entered into a non-binding letter of intent to acquire Rendiatech, Ltd.,... Full story

Yahoo Finance • last month

Nuwellis signs letter of intent to acquire Rendiatech

Nuwellis (NASDAQ:NUWE [https://seekingalpha.com/symbol/NUWE]) has signed a non-binding letter of intent [https://seekingalpha.com/pr/20204874-nuwellis-signs-letter-of-intent-to-explore-acquisition-of-rendiatech-ltd-a-real-time-fluid] to ac... Full story

Yahoo Finance • last month

Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company

Proposed acquisition supports strategy to drive technology expansion of fluid management offering to include continuous renal health monitoring technologies supporting the full patient journey, from early risk assessment to targeted fluid... Full story

Yahoo Finance • last month

Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

MINNEAPOLIS, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company delivering fluid management solutions for critically ill patients, today announced that it will present at the Webull Financial Co... Full story

Yahoo Finance • last month

Nuwellis outlines Q3 recovery and strategic shift after resolving $400,000 back order

Earnings Call Insights: Nuwellis, Inc. (NUWE) Q2 2025 MANAGEMENT VIEW * John L. Erb, CEO, reported that Nuwellis entered the second quarter with an emphasis on strengthening operational discipline, commercial execution, and strategic i... Full story

Yahoo Finance • last month

Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights

MINNEAPOLIS, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical technology company dedicated to transforming care for fluid overload patients, today announced financial results for the second quar... Full story

Yahoo Finance • 2 months ago

Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus

MINNEAPOLIS, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company delivering fluid management solutions for critically ill patients, today announced its decision to exit international operations i... Full story

Yahoo Finance • 2 months ago

Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025

MINNEAPOLIS, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on fluid management, today announced that it will postpone its 2025 second quarter earnings release and conference call, o... Full story

Yahoo Finance • 2 months ago

Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code

MINNEAPOLIS, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming fluid management, today announced that the first patients have been successfully treated with Aquadex® u... Full story

Yahoo Finance • 2 months ago

Nuwellis Stockholders Approve All Proposals at Special Meeting

MINNEAPOLIS , Aug. 04, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on fluid management, today announced that stockholders approved all proposals presented at the company’s Special Meeting... Full story

Yahoo Finance • 2 months ago

Nuwellis Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference

MINNEAPOLIS, July 23, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc., today announced that John Erb, President and Chief Executive Officer of Nuwellis, participated in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conferen... Full story

Yahoo Finance • 2 months ago

Nuwellis Regains Compliance with Nasdaq Listing Requirements

MINNEAPOLIS, July 23, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on fluid management solutions for patients with fluid overload, today announced that it has regained compliance with the N... Full story

Yahoo Finance • 2 months ago

Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025

MINNEAPOLIS, July 22, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage medical technology company focused on transforming the lives of people with fluid overload, today announced that it will release financial r... Full story

Yahoo Finance • 2 months ago

Nuwellis stock falls after company terminates REVERSE-HF clinical trial

Investing.com -- Nuwellis Inc (NASDAQ:NUWE) stock tumbled 10% after the company announced the termination of its REVERSE-HF clinical trial, which was evaluating ultrafiltration versus IV loop diuretic therapy for fluid management in hospit... Full story

Yahoo Finance • 2 months ago

Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care

WHOWHATWHENWHYNuwellis, Inc. Termination of the REVERSE-HF clinical trial July 17, 2025To redirect resources toward outpatient markets where scalable impact is highest. MINNEAPOLIS, July 17, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. t... Full story